Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for liver function in childhood ALL maintenance therapy
IRCT20190107042281N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of allopurinol in acute lymphoblastic leukemia (ALL), sponsored by Arak University of Medical Sciences. Primary endpoint: Change in liver function tests. Started Jun 2019; status: completed.
02
Drugs
allopurinol
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on IRCT20190107042281N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190107042281N1.